Searched for
INTERNATIONAL CDMO CAPABILITIES
China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...25 May, 2025, 12.39 PM IST- Stocks to buy today: Affle continues to be Elara’s top pick in the internet space; Motilal initiates coverage on Jindal StainlessBrokerage firms are bullish on Jindal Stainless due to expansion plans and projected revenue and profit growth. Navin Fluorine's Pharma CDM...13 May, 2025, 10.01 AM IST
- Macquarie initiates coverage on Divi’s Labs, 3 CRDMO firms with up to 40% upside potentialThe global brokerage firm highlights that Indian CDMO companies trade at a 2-year forward EV/EBITDA of 20x, compared to 16x for regional an...19 Feb, 2025, 02.54 PM IST
- Suven Pharma sets sights on M&As to scale up tech expertise & order bookSuven Pharmaceuticals, backed by Advent International, is eyeing further mergers and acquisitions to bolster its capabilities and order boo...10 Dec, 2024, 11.58 PM IST
- CDMO is the biggest theme; select companies can grow 5 times in next 10 years: Madhusudan KelaGeopolitical tensions between the US and China are pushing contract manufacturing business to India. Madhusudan Kela believes that the Cont...28 Oct, 2024, 08.11 AM IST
- Piramal Pharma stock in focus on $80 million expansion plan for Kentucky injectables facilityPiramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet growing injectabl...01 Oct, 2024, 09.53 AM IST
- Suven, with Cohance and more, wants to become a CDMO powerhouse: Annaswamy Vaidheesh, executive chairman"We want to be a diversified, end-to-end capability outsourcing partner, serving customers from development to commercial scale. Doing this...02 Mar, 2024, 12.46 AM IST
- Suven-Cohance Lifesciences merger announced to create 1st listed PE-led contract manufacturer in Indian pharmaSuven has been 50% owned by Advent since 2022 acquisition, with the remaining with public and institutional shareholders while Cohance is w...29 Feb, 2024, 11.27 PM IST
- Suven Pharma, Cohance Lifesciences to merge to bolster CDMO businessPromoter of Suven Pharma, Advent International, had said last year that it would merge the two businesses post the buyout of its significan...29 Feb, 2024, 09.10 PM IST
- Supriya Lifescience to bet on R&D, expansion to grow revenuesSupriya Lifescience, an active pharmaceutical ingredient (API) maker based in Mumbai, aims to double its revenue in the next three years. T...20 Dec, 2023, 12.24 AM IST
- PE Advent completes acquisition of Suven Pharma, appoints new Board and management teamPrivate equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...29 Sep, 2023, 09.59 PM IST
- Gland Pharma to invest Rs 400 crore to expand its Telangana plantThe expanded site is envisaged to meet the national and international regulations to be followed in the manufacturing of the biological pro...20 Feb, 2023, 04.49 PM IST
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...27 Dec, 2022, 06.27 AM IST
- Gland Pharma falls 5% after announcing Cenexi Group acquisitionCenexi, along with its subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of ph...30 Nov, 2022, 01.26 PM IST
- Gland Pharma acquires French CDMO Cenexi for €120 millionFounded in 2004, Cenexi, along with its subsidiaries, is engaged primarily in the business of CDMO of pharmaceutical products with expertis...29 Nov, 2022, 06.23 PM IST
- Jonathan Hunt on growth triggers which led to upgrade of Syngene sales guidance“ Syngene has signed a 10-year strategic deal with Zoetis in animal health: It was a real piece of innovation from Zoetis and we are deligh...21 Jul, 2022, 02.24 PM IST
- Piramal Enterprise gets board nod for demerger and listing of pharma businessThe pharmaceuticals business will get vertically demerged from Piramal Enterprises and consolidated under Piramal Pharma Ltd (PPL), the gro...07 Oct, 2021, 10.16 PM IST
Load More
